H.C. Wainwright Starts Windtree Therapeutics (WINT) at Neutral, 'Istaroxime Poised to Navigate Late-Stage Development'

Go back to H.C. Wainwright Starts Windtree Therapeutics (WINT) at Neutral, 'Istaroxime Poised to Navigate Late-Stage Development'
(NASDAQ: WINT) Delayed: 0.11 --0 (-0%)
Previous Close $0.11    52 Week High $4.42 
Open $0.11    52 Week Low $1.44 
Day High $0.11    P/E N/A 
Day Low $0.11    EPS $0.00 
Volume 6,127